| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes
|
Yandrapalli, Srikanth
|
|
2019
|
213 |
C |
p. 18-29
|
artikel
|
| 2 |
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study
|
Warraich, Haider J.
|
|
2019
|
213 |
C |
p. 91-96
|
artikel
|
| 3 |
Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial
|
Jensen, Lisette Okkels
|
|
2019
|
213 |
C |
p. 1-7
|
artikel
|
| 4 |
Corrigendum to “A prospective 5-year study of exercise performance following melody valve implant”, American Heart Journal. 2018 Dec 29; 209:47–53
|
Priromprintr, B
|
|
2019
|
213 |
C |
p. 126
|
artikel
|
| 5 |
Editorial Board
|
|
|
2019
|
213 |
C |
p. iv
|
artikel
|
| 6 |
Factors for modifying the termination of resuscitation rule in out-of-hospital cardiac arrest
|
Yoon, Jae Chol
|
|
2019
|
213 |
C |
p. 73-80
|
artikel
|
| 7 |
Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial
|
van Zandvoort, Laurens J.C.
|
|
2019
|
213 |
C |
p. 66-72
|
artikel
|
| 8 |
Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation—Individual patient data pooled analysis from 6 randomized controlled trials
|
Konigstein, Maayan
|
|
2019
|
213 |
C |
p. 105-111
|
artikel
|
| 9 |
Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)
|
Decker, Paul A.
|
|
2019
|
213 |
C |
p. 30-34
|
artikel
|
| 10 |
Information for Readers
|
|
|
2019
|
213 |
C |
p. v
|
artikel
|
| 11 |
Letter to the editor regarding the results of the retrospective study “Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock” published in the American Heart Journal
|
Sacco, Alice
|
|
2019
|
213 |
C |
p. 123
|
artikel
|
| 12 |
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
|
Haas, Sylvia
|
|
2019
|
213 |
C |
p. 35-46
|
artikel
|
| 13 |
Response to the letter to the editor regarding the results of the retrospective study “Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock” published in the American Heart Journal
|
Hsu, Steven
|
|
2019
|
213 |
C |
p. 124-125
|
artikel
|
| 14 |
Right ventricular function in patients with pulmonary regurgitation with versus without tetralogy of Fallot
|
Larios, Guillermo
|
|
2019
|
213 |
C |
p. 8-17
|
artikel
|
| 15 |
Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program
|
Gutierrez, J. Antonio
|
|
2019
|
213 |
C |
p. 47-56
|
artikel
|
| 16 |
Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)
|
Pina, Liza Miriam
|
|
2019
|
213 |
C |
p. 97-104
|
artikel
|
| 17 |
Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease
|
van den Berg, M. Johanneke
|
|
2019
|
213 |
C |
p. 112-122
|
artikel
|
| 18 |
Table of Contents
|
|
|
2019
|
213 |
C |
p. i-iii
|
artikel
|
| 19 |
Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
|
Åkerblom, Axel
|
|
2019
|
213 |
C |
p. 57-65
|
artikel
|
| 20 |
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II
|
Inohara, Taku
|
|
2019
|
213 |
C |
p. 81-90
|
artikel
|
Tijdschrift beschrijving